Molly Henderson - 07 Apr 2025 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role: CFO and CBO
Signature: /s/ Molly Henderson
Issuer symbol: PHAT
Transactions as of: 07 Apr 2025
Net transactions value: -$16,740
Form type: 4
Filing time: 08 Apr 2025, 17:01:33 UTC
Previous filing: 03 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PHAT	Common Stock	Sale	$16,740	-3,678	-3.9%	$4.55	89,868	07 Apr 2025	Direct	F1, F2
holding	PHAT	Common Stock						1,911	07 Apr 2025	By 401(k)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in two transactions at prices $4.55 to $4.57. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.

The price reported in Column 4 is a weighted average price. These shares were sold in two transactions at prices $4.55 to $4.57. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.